<DrugInformationSummary id="CDR0000795372"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Talazoparib tosylate works by blocking the activity of PARP enzymes, which help repair damaged DNA in cells. Cancer cells with BRCA mutations or certain other gene mutations cannot use a key DNA repair process called homologous recombination (HR) and need PARP enzymes to survive. Blocking the activity of PARP enzymes causes these cancer cells to die. Talazoparib tosylate is a type of targeted therapy drug called a PARP inhibitor. It is a small-molecule drug (a drug that can enter cells easily).</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/talazoparibtosylate">Talazoparib Tosylate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000694964">talazoparib tosylate</TerminologyLink><GlossaryLink ref="CDR0000795345">talazoparib tosylate</GlossaryLink><USBrandNames><USBrandName>Talzenna</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>TA-luh-ZOH-puh-rib TOH-suh-layt</TermPronunciation><MediaLink ref="CDR0000796122" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000796123" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Talazoparib Tosylate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Talazoparib tosylate
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000774531" dictionary="Cancer.gov" audience="Patient">HER2 negative</GlossaryTermRef> and has certain <GlossaryTermRef href="CDR0000046384" dictionary="Cancer.gov" audience="Patient">germline mutations</GlossaryTermRef> in the <GeneName><GlossaryTermRef href="CDR0000046047" dictionary="Cancer.gov" audience="Patient">BRCA1</GlossaryTermRef></GeneName> or <GeneName><GlossaryTermRef href="CDR0000046742" dictionary="Cancer.gov" audience="Patient">BRCA2</GlossaryTermRef></GeneName> gene. It is used alone in adults whose cancer has spread to nearby tissues.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000445079" dictionary="Cancer.gov" audience="Patient">Prostate cancer</GlossaryTermRef></Strong> that has certain mutations in genes involved in the <GlossaryTermRef href="CDR0000801715" dictionary="Cancer.gov" audience="Patient">HRR pathway</GlossaryTermRef>. It is used with <GlossaryTermRef href="CDR0000740024" dictionary="Cancer.gov" audience="Patient">enzalutamide</GlossaryTermRef> in adults whose cancer has spread to other parts of the body and is <GlossaryTermRef href="CDR0000753525" dictionary="Cancer.gov" audience="Patient">castrate resistant</GlossaryTermRef> (has not responded to treatments that lower <GlossaryTermRef href="CDR0000045581" dictionary="Cancer.gov" audience="Patient">testosterone</GlossaryTermRef> levels).</ListItem>
   
   </ItemizedList>
  <Para id="_4">Talazoparib tosylate
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Talazoparib Tosylate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/694964">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.37">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a618070.html">Talazoparib Tosylate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.38"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.39">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2025/xtandi-talzenna-metastatic-prostate-cancer">Combination Therapy for Metastatic Prostate Cancer Helps Some Men Live Longer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/fda-talazoparib-enzalutamide-prostate-cancer">FDA Approves New Initial Treatment Option for Some Metastatic Prostate Cancers</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C152494">Find Clinical Trials for Talazoparib Tosylate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2019-02-28</DateFirstPublished><DateLastModified>2025-03-11</DateLastModified></DrugInformationSummary>
